Neoadjuvant therapy for resectable and borderline resectable pancreatic cancer

被引：4
|
作者：
Kumar, Rachit [1 ]
Jabbour, Salma K. [2 ]
机构：
[1] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Dept Radiat Oncol & Mol Radiat Sci, Baltimore, MD USA
[2] Rutgers State Univ, Robert Wood Johnson Med Sch, Rutgers Canc Inst New Jersey, Dept Radiat Oncol, 195 Little Albany St, New Brunswick, NJ 08903 USA
来源：
JOURNAL OF RADIATION ONCOLOGY | 2013年 / 2卷 / 04期
关键词：
Pancreatic cancer; Neoadjuvant therapy; Radiation therapy; Resectable; Borderline resectable;
D O I：
10.1007/s13566-013-0120-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Neoadjuvant chemoradiation for resectable and borderline resectable pancreatic cancer has been widely investigated in the past two decades. Research demonstrates that this therapy may help improve surgical margins, reduce rates of lymph node positivity, allow for earlier initiation of systemic therapy, and select for patients with aggressive disease in whom surgery may not be warranted. This review presents the data for neoadjuvant chemoradiation in pancreatic cancer with a focus on resectable and borderline resectable disease.
引用
收藏
页码：353 / 367
页数：15
相关论文
共 50 条
  • [1] Neoadjuvant Therapy for Resectable or Borderline Resectable Pancreatic Cancer
    Lee, Sang Hoon
    [J]. KOREAN JOURNAL OF GASTROENTEROLOGY, 2024, 84 (03): : 103 - 110
  • [2] Strategy of Neoadjuvant Therapy for Resectable/Borderline Resectable Pancreatic Cancer
    Hashimoto, D.
    Satoi, S.
    Yamamoto, T.
    Yamaki, S.
    Hirooka, S.
    Ishida, M.
    Ikeura, T.
    Sekimoto, M.
    [J]. PANCREAS, 2021, 50 (07) : 1064 - 1064
  • [3] Neoadjuvant Therapy in Borderline Resectable Pancreatic Cancer
    Barreto, Savio George
    Shrikhande, Shailesh, V
    Sirohi, Bhawna
    [J]. INDIAN JOURNAL OF SURGICAL ONCOLOGY, 2024, 15 (SUPPL 2) : 249 - 254
  • [4] Neoadjuvant Chemoradiotherapy for Resectable and Borderline Resectable Pancreatic Cancer
    Attaallah, Wafi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (28) : 3346 - +
  • [5] Neoadjuvant Chemoradiotherapy for Resectable and Borderline Resectable Pancreatic Cancer
    Hayakawa, S.
    Karasawa, K.
    Fujisawa, T.
    Ito, K.
    Shibata, Y.
    Shimizuguchi, T.
    Nihei, K.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E236 - E236
  • [6] Neoadjuvant or Adjuvant Therapy for Resectable or Borderline Resectable Pancreatic Cancer: Which Is Preferred?
    O'Reilly, Eileen M.
    Ferrone, Cristina
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (16) : 1757 - +
  • [7] Neoadjuvant chemoradiation with IMRT in resectable and borderline resectable pancreatic cancer
    Kharofa, Jordan
    Tsai, Susan
    Kelly, Tracy
    Wood, Clint
    George, Ben
    Ritch, Paul
    Wiebe, Lauren
    Christians, Kathleen
    Evans, Douglas B.
    Erickson, Beth
    [J]. RADIOTHERAPY AND ONCOLOGY, 2014, 113 (01) : 41 - 46
  • [8] Editorial: Neoadjuvant treatment for resectable and borderline resectable pancreatic cancer
    Massani, Marco
    Stecca, Tommaso
    [J]. FRONTIERS IN ONCOLOGY, 2023, 13
  • [9] Neoadjuvant treatment of primarily resectable and borderline resectable pancreatic cancer
    Scheufele, F.
    Friess, H.
    [J]. CHIRURG, 2020, 91 (05): : 391 - 395
  • [10] Neoadjuvant Treatment in Patients With Resectable and Borderline Resectable Pancreatic Cancer
    Janssen, Quisette P.
    O'Reilly, Eileen M.
    Van Eijck, Casper H. J.
    Groot Koerkamp, Bas
    [J]. FRONTIERS IN ONCOLOGY, 2020, 10
12345